Defeating Migraine Pain with Triptans: A Race against the Development of Cutaneous Allodynia

Annals of Neurology

Volumn 55, Issue 1, 2004, Pages 19-26

  Burstein, Rami ^a,b,c   Collins, Beth ^a   Jakubowski, Moshe ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXAZOLIDINONE DERIVATIVE; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; TRIAZOLE DERIVATIVE; ZOLMITRIPTAN;

ADOLESCENT; ADULT; ALLODYNIA; ANALGESIA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INJECTION; MECHANICAL STIMULATION; MIGRAINE; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN; SKIN STIMULATION; THERMAL STIMULATION; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; HUMANS; INJECTIONS; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SEROTONIN AGONISTS; SKIN; SUMATRIPTAN; TIME FACTORS; TRIAZOLES; TRYPTAMINES;

EID: 0347319254     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10786     Document Type: Article

References (28)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-69.
2. Olesen J, Cutrer FM. Migraine with aura and its subforms. In: Olesen J, Tfelt-Hansen P, Welch K, eds. The headaches. New York: Raven Press, 2000:345-357.
3. Zagami AS, Rasmussen BK. Symptomology of migraine without aura. In: Olesen J, Tfelt-Hansen P, Welch MA, eds. The headaches. New York: Raven Press, 2000:337-343.
4. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47:614-624.
5. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996;384:560-564.
6. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998;79:964-982.
7. Burstein R, Cutrer FM, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703-1709.
8. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;89:107-110.
9. Humphrey PP, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991;12:444-446.
10. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991;338:13-17.
11. Rederich G, Rapoport A, Cutler N, et al. Oral sumatriptan for the long-term treatment of migraine: clinical findings. Neurology 1995;45:S15-S20.
12. Dahlof CG, Lipton RB, McCarroll KA, et al. Within-patient consistency of response of rizatriptan for treating migraine. Neurology 2000;55:1511-1516.
13. Headache-classification-committee-of-the-International-Headache- Society. Classification and diagnosis criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 1988;8:1-92.
14. Saxena PR, Tfelt-Hansen P. Triptans, 5-HT1b/1d receptors agonists in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch K, eds. The headaches. Vol 2. Philadelphia: Lippincott, 2000:411-438.
15. Rance D, Clear N, Dallman L, et al. Physicochemical comparison of eletriptan and other 5-HT1D-like agonists as a predictor of oral absorption potential. Headache 1997;37:328.
16. Fruhstorfer H, Lindblom U, Schmidt WC. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976;39:1071-1075.
17. Lindblom U. Analysis of abnormal touch, pain, and temperature sensation in patients. In: Boivie J, Hansson P, Lindblom U, eds. Touch, temperature and pain in health and disease: mechanism and assessments. Vol 3. Seattle: IASP Press, 1994: 63-84.
18. Harrison JL, Davis KD. Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans. Pain 1999; 83:123-135.
19. Strigo IA, Carli F, Bushnell MC. Effect of ambient temperature on human pain and temperature perception. Anesthesiology 2000;92:699-707.
20. Zar JH. Biostatistical analysis. 4th ed. Englewood Cliffs, NJ: Prentice-Hall, 1998.
21. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22: 1035-1048.
22. Bousser MG, D'Allens H, Richard A. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group. J Intern Med 1993;234:211-216.
23. Dahlof C, Hogenhuis L, Olesen J, et al. Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study. Eur J Neurol 1998;5:469-477.
24. Rapoport AM, Ramadan NM, Adelman JU, et al. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology 1997;49:1210-1218.
25. Dahlof C, Diener HC, Goadsby PJ, et al. Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study. Eur J Neurol 1998;5:535-543.
26. Tfelt-Hansen P, Teall J, Rodriguez F, et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache 1998;38:748-755.
27. Gruffyd-Jones K, Kies B, Middleton A, et al. Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. Eur J Neurol 2001; 8:237-245.
28. Burstein R, Jakubowski M. Defeating intracranial pain with triptan in an animal model of migraine: a race against developing central sensitization and cutaneous allodynia. Ann Neurol 2003; DOI 10.1002/ana.10786.